Viewing Study NCT00637832


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2025-12-28 @ 2:28 AM
Study NCT ID: NCT00637832
Status: TERMINATED
Last Update Posted: 2022-01-06
First Post: 2008-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma
Sponsor: University of Southampton
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module